The type 2 cytokine Fc–IL-4 revitalizes exhausted CD8+ T cells against cancerBing Feng, Li Tang, Zhiliang Bai et al.|Nature|2024Cited by 118
HMGB3 promotes PARP inhibitor resistance through interacting with PARP1 in ovarian cancerHanlin Ma, Beihua Kong, Jia Yan et al.|Cell Death and Disease|2022Cited by 48